Market Research Reports and Industry Reports

CanBas Co Ltd (4575) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that provides drugs. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It product under development is CBP501, a modified synthetic peptide enhancing the efficacy of cisplatin without adding toxicity. CanBas CBP501 is in US Phase II development for first-line treatment of late stage malignant pleural mesothelioma and non-small cell lung cancer. The companys other drug candidates, CBS9106, an orally-active synthetic small molecule of molecular mass 420, is in preclinical stage, and CBS2400 program is currently in the lead optimization stage of development. It also develops techniques to determine the drug specific sensitivity of individual cancer from a patient. CanBas is headquartered in Numazu, Japan.

CanBas Co Ltd (4575) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CanBas Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CanBas Enters into Research Agreement with Fujifilm 10
CanBas Enters into Research Agreement with University of Shizuoka 11
Licensing Agreements 12
Stemline Therapeutics Enters into Licensing Agreement with CanBas 12
Stemline Therapeutics Enters into Licensing Agreement with CanBas for CBS-9106 13
CanBas Co Ltd - Key Competitors 14
CanBas Co Ltd - Key Employees 15
CanBas Co Ltd - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Clinical Trials 17
Feb 21, 2017: Stemline Therapeutics Provides Update on SL-801 17
May 03, 2016: Stemline Therapeutics Clears First Cohort of Patients in Ongoing SL-801 Phase 1 Trial 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
CanBas Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CanBas Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CanBas Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
CanBas Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CanBas Enters into Research Agreement with Fujifilm 10
CanBas Enters into Research Agreement with University of Shizuoka 11
Stemline Therapeutics Enters into Licensing Agreement with CanBas 12
Stemline Therapeutics Enters into Licensing Agreement with CanBas for CBS-9106 13
CanBas Co Ltd, Key Competitors 14
CanBas Co Ltd, Key Employees 15

CanBas Co Ltd (4575) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that provides drugs. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle.

USD 250View Report

CanBas Co Ltd Strategic Analysis Review- CanBas Co Ltd SWOT, Outlook, Operations and Financial Profile

CanBas Co Ltd Company Profile provides strategic analysis of CanBas Co Ltd Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200View Report

Samsung Biologics Co Ltd (207940) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The companys business activities includes process development, contract manufacturing, aseptic fill and finish and project management. Its

USD 250View Report

Ratchaburi Electricity Generating Holding Public Co Ltd (RATCH) - Power - Deals and Alliances Profile

Ratchaburi Electricity Generating Holding Public Company Limited (RATCH) is an independent power producer that invests in subsidiaries, associates and joint ventures which operate electricity generating and related businesses. The company

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :19
Country :Japan
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube